FY2028 Earnings Forecast for JNJ Issued By Leerink Partnrs

Johnson & Johnson (NYSE:JNJ - Free Report) - Analysts at Leerink Partnrs boosted their FY2028 EPS estimates for shares of Johnson & Johnson in a research report issued to clients and investors on Thursday, July 17th. Leerink Partnrs analyst D. Risinger now forecasts that the company will post earnings of $13.63 per share for the year, up from their previous forecast of $12.77. Leerink Partnrs currently has a "Hold" rating on the stock. The consensus estimate for Johnson & Johnson's current full-year earnings is $10.58 per share.

JNJ has been the topic of a number of other reports. Piper Sandler restated an "overweight" rating on shares of Johnson & Johnson in a report on Thursday. The Goldman Sachs Group upgraded shares of Johnson & Johnson from a "neutral" rating to a "buy" rating and upped their target price for the company from $157.00 to $172.00 in a report on Wednesday, April 9th. Raymond James Financial reduced their target price on shares of Johnson & Johnson from $165.00 to $162.00 and set an "outperform" rating on the stock in a report on Monday, April 14th. Morgan Stanley upped their price objective on shares of Johnson & Johnson from $171.00 to $176.00 and gave the company an "equal weight" rating in a research note on Thursday. Finally, Guggenheim boosted their target price on shares of Johnson & Johnson from $164.00 to $167.00 and gave the company a "neutral" rating in a report on Thursday. Eleven research analysts have rated the stock with a hold rating, nine have given a buy rating and two have issued a strong buy rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and an average price target of $172.87.

Johnson & Johnson Price Performance

NYSE:JNJ opened at $163.65 on Monday. The firm has a market cap of $393.75 billion, a price-to-earnings ratio of 17.50, a price-to-earnings-growth ratio of 2.08 and a beta of 0.41. The company has a current ratio of 1.26, a quick ratio of 1.03 and a debt-to-equity ratio of 0.49. The company's 50-day moving average is $154.29 and its two-hundred day moving average is $155.12. Johnson & Johnson has a 12-month low of $140.68 and a 12-month high of $169.99.

Johnson & Johnson (NYSE:JNJ - Get Free Report) last released its quarterly earnings data on Wednesday, July 16th. The company reported $2.77 EPS for the quarter, topping the consensus estimate of $2.68 by $0.09. Johnson & Johnson had a net margin of 25.00% and a return on equity of 33.07%. The business had revenue of $23.74 billion for the quarter, compared to analyst estimates of $22.85 billion. During the same period in the previous year, the firm earned $2.82 EPS. The business's revenue for the quarter was up 5.8% compared to the same quarter last year.

Hedge Funds Weigh In On Johnson & Johnson

Institutional investors and hedge funds have recently bought and sold shares of the stock. Norges Bank purchased a new position in Johnson & Johnson in the 4th quarter valued at about $4,390,037,000. Nuveen LLC acquired a new position in shares of Johnson & Johnson in the first quarter worth about $1,369,188,000. GAMMA Investing LLC boosted its holdings in Johnson & Johnson by 24,450.4% in the first quarter. GAMMA Investing LLC now owns 7,215,367 shares of the company's stock valued at $1,196,596,000 after purchasing an additional 7,185,977 shares during the last quarter. Bank of New York Mellon Corp boosted its holdings in Johnson & Johnson by 26.4% in the first quarter. Bank of New York Mellon Corp now owns 23,182,464 shares of the company's stock valued at $3,844,580,000 after purchasing an additional 4,842,582 shares during the last quarter. Finally, Janus Henderson Group PLC boosted its holdings in Johnson & Johnson by 134.5% in the fourth quarter. Janus Henderson Group PLC now owns 7,948,508 shares of the company's stock valued at $1,149,536,000 after purchasing an additional 4,559,147 shares during the last quarter. Hedge funds and other institutional investors own 69.55% of the company's stock.

Johnson & Johnson Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, September 9th. Investors of record on Tuesday, August 26th will be given a dividend of $1.30 per share. This represents a $5.20 dividend on an annualized basis and a yield of 3.18%. The ex-dividend date is Tuesday, August 26th. Johnson & Johnson's dividend payout ratio (DPR) is presently 55.61%.

About Johnson & Johnson

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.